Amber Enterprises India Ltd

Similar documents
Mahindra & Mahindra Ltd.

Maruti Suzuki India BUY. Performance Update. CMP `9,315 Target Price `10,820. 1QFY2019 Result Update Automobile. Historical share price chart

ITC ACCUMULATE. Performance Highlights CMP. `257 Target Price `284. 3QFY2017 Result Update FMCG. Investment Period 12 Months

Mahindra & Mahindra Ltd.

Garware Wall Ropes ACCUMULATE. Performance Highlights CMP. `550 Target Price `618. 2QFY2017 Result Update Textile. Investment Period 12 months

Bata India BUY. Performance Update. CMP Target Price `842. 1QFY2019 Result Update Footwear. Historical share price chart.

Blue Star Ltd BUY. Performance Update. CMP Target Price `703 `867. 1QFY2019 Result Update Cons. Durable. 3-year price chart.

TV Today Network BUY. Performance Update CMP. `323 Target Price `498. 3QFY2019 Result Update Media. Investment Period 12 Months

Parag Milk Foods BUY. Performance Update CMP. `256 Target Price `330. 2QFY2019 Result Update Dairy Products. Investment Period 12 Months

Bata India BUY. Performance Update. CMP `1,008 Target Price `1,243. 2QFY2019 Result Update Footwear. Historical share price chart.

Music Broadcast BUY. Performance Update. CMP Target Price `293 `475. 3QFY2019 Result Update Media. Stock Info Sector Market Cap (Rs cr) Media

Maruti Suzuki India BUY. Performance Update. CMP `6,705 Target Price `8,552. 2QFY2019 Result Update Automobile. Historical share price chart

Music Broadcast BUY. Performance Update. CMP Target Price `329 `475. 2QFY2019 Result Update Media. Historical share price chart.

Hindustan Media Ventures

GMM Pfaudler Limited BUY. Performance Update CMP. `945 Target Price ` QFY2019 Result Update Industrial Machinery. Investment Period 12 Months

Procter & Gamble Hygiene & Health Care

Asian Granito BUY. Performance Highlights CMP. `270 Target Price `351. Outlook and valuation. 3QFY2017 Result Update Ceramics

Parag Milk Foods BUY. Performance Update CMP. `324 Target Price `410. 1QFY2019 Result Update Dairy Products. Investment Period 12 Months

Quick take. Ruchira Papers Ltd. BUY. Creating value through paper. Target Price. Investment Period 12 Months. 3 year daily price chart.

Greenply Industries BUY. The plywood maker for growing India. Target Price. Initiating Coverage Plywood. 3-year price chart.

KEI Industries BUY. Performance Update. CMP Target Price `433 `508. 4QFY2018 Result Update Cable. Historical share price chart.

Amara Raja Batteries BUY. Performance Highlights. CMP `1,010 Target Price `1,167. 2QFY2017 Result Update Auto Ancillary. 3-year price chart

KEI Industries BUY. Performance Update. Target Price. 3QFY2018 Result Update Cable. Historical share price chart. Key Financials

TV Today Network BUY. Performance Update. CMP Target Price `315 `385. 2QFY2017 Result Update Media. Historical share price chart.

Mahindra & Mahindra Ltd.

Coal India ACCUMULATE. Performance Highlights CMP. `338 Target Price `380. Outlook and valuation. 2QFY2016 Result Update Mining

Jindal Steel & Power BUY. CMP Target Price `200 `320. 1QFY2019 Result Update Steel & Power. Performance Update

Inox Wind BUY. Performance Highlights. CMP Target Price `390 `505. 2QFY2016 Result Update Capital Goods. 3 year price chart

LT Foods BUY. Performance Update. CMP Target Price `92 `128. 3QFY2018 Result Update Media February 12, 2018

Hero MotoCorp ACCUMULATE. Performance Highlights. CMP `3,226 Target Price `3,466. 3QFY2017 Result Update Automobile. 3-year price chart

Inox Wind BUY. Performance Highlights. CMP Target Price `242 `286. 4QFY2016 Result Update Capital Goods. 3 year price chart

CCL Products BUY. Brewing Steadily. CMP Target Price `300 `360. Initiating Coverage Coffee. January 4, year price chart

Blue Star Ltd BUY. Performance Update. CMP Target Price `754 `867. 4QFY2018 Result Update Cons. Durable. 3-year price chart.

Quick take. VIP Industries BUY. Travelling smart on the luggage track. CMP Target Price `153 ` year daily price chart

LT Foods BUY. Performance Update. CMP Target Price `76 `128. 4QFY2018 Result Update Media

ACC BUY. Performance Highlights. CMP `1,397 Target Price `1,630. 3QCY2015 Result Update Cement

Goodyear India BUY. Company Update. CMP Target Price `515 `631. Company Update Tyres. 3-year Daily Price Chart. Key Financials

Rallis India NEUTRAL. Performance Highlights CMP. `237 Target Price - 1QFY2018 Result Update Agrichemical. Investment Period - 3-year price chart

Ambuja Cements ACCUMULATE. Performance Highlights. CMP Target Price `207 `233. 3QCY2015 Result Update Cement. Quarterly results (Standalone)

Quick take. Ashok Leyland Ltd BUY. Scrappage policy to drive faster growth. Target Price. Investment Period 12 Months. 3-year price chart

Rallis India NEUTRAL. Performance Highlights CMP. `215 Target Price - 3QFY2017 Result Update Agrichemical. Investment Period - 3-year price chart

Rallis India SELL. Performance Highlights. `231 Target Price 189 CMP. 2QFY2018 Result Update Agrichemical. Investment Period 12 months

Century Plyboards Ltd

Matrimony.com Ltd BUY. Performance Update. Target Price `1,016. 4QFY2018 Result Update Cable. Historical share price chart.

CCL Products BUY. Performance Update. CMP Target Price `278 `360. 3QFY2018 Result Update Coffee. Historical share price chart.

Rallis India NEUTRAL. Performance Highlights CMP. `242 Target Price - 4QFY2017 Result Update Agrichemical. Investment Period - 3-year price chart

Matrimony.com Ltd BUY. A complete package from matchmaking to wedding. Target Price. Initiating Coverage Internet Software & Services

Transport Corporation of India

Apollo Micro Systems Ltd

Federal Bank BUY. Performance Highlights. Target Price. 1QFY2018 Result Update Banking. Stock Info Sector

Tata Steel NEUTRAL. Performance Highlights CMP. `226 Target Price - 2QFY2016 Result Update Steel. Investment Period - 3-year price chart

Sanofi India NEUTRAL. Performance Highlights. CMP `4,301 Target Price - 4QCY2016 Result Update Pharmaceutical. Investment Period - 3-year price chart

TV Today Network BUY. Go with the market leader. CMP Target Price `297 `363. Initiating Coverage Media. 3-year price chart

HDFC Bank BUY. Performance Highlights. CMP `2,145 Target Price `2,500. Q3FY2019 Result Update Banking. 3-year price chart. Key financials (Standalone)

MISHRA DHATU NIGAM Ltd.

Goodyear India ACCUMULATE. Performance Highlights. CMP Target Price `326 `374. 1QCY2012 Result Update Tyres. Key financials

Hero MotoCorp ACCUMULATE. Performance Highlights. CMP `3,718 Target Price `4,130. 1QFY2018 Result Update Automobile. 3-year price chart

Sanofi India ACCUMULATE. Performance Highlights. CMP `4,410 Target Price `4,738. 1QCY2016 Result Update Pharmaceutical. 3-year price chart

GAIL India NEUTRAL. Performance Highlights CMP. `363 Target Price - 2QFY2013 Result Update Oil & Gas. Investment Period -

Sanofi India NEUTRAL. Performance Highlights. CMP `4,007 Target Price - 3QCY2017 Result Update Pharmaceutical. Investment Period 12 months

Tata Consultancy Services (TCS)

Sanofi India NEUTRAL. Performance Highlights. CMP `4,007 Target Price - 2QCY2017 Result Update Pharmaceutical. 3-year price chart.

Varroc Engineering Ltd.

Newgen Software Technologies Ltd

LIC Housing Finance BUY. Performance Highlights. CMP Target Price `532 `630. 3QFY2017 Result Update HFC. 3-Year Daily Price Chart

Graphite India BUY. Performance Highlights. CMP Target Price `88 `109. 1QFY2012 Result Update Capital Goods

SpiceJet BUY. Performance Highlights CMP. `32 Target Price `43. 1QFY2013 Result Update Airlines. Investment Period 12 Months.

HDFC Bank BUY. Operating performance strong; improved NIM. CMP `2,268 Target Price `2,500. Q4FY2019 Result Update Banking. 3-year price chart

MRF BUY. Performance Highlights. CMP `9,407 Target Price `11,343. Company Update Automobile. Key financials

Future Supply Chain Solutions Ltd

HDFC Bank BUY. Performance Highlights. CMP `1,965 Target Price `2,350. Q2FY2019 Result Update Banking. 3-year price chart. Exhibit 1: Key Financials

ICICI Bank BUY. Performance Highlights. CMP Target Price `343 `460. Q3FY2019 Result Update Banking. 3-year price chart. Exhibit 1: Key Financials

Axis Bank BUY. CMP Target Price `620 `750. Update Bank. Earnings to normalize with stabilizing credit costs. 3-year price chart.

NEUTRAL. Neogen Chemicals Ltd. Issue Open: April 24, 2019 Issue Close: April 26, IPO Note Specialty Chemicals

ICICI Bank BUY. Performance Highlights. CMP Target Price `328 `416. 3QFY2018 Result Update Banking. 3-year price chart. Key financials (Standalone)

Graphite India BUY. Performance Highlights CMP. `93 Target Price `124. 4QFY2012 Result Update Capital Goods. Investment Period 12 Months

Cadila Healthcare NEUTRAL. Performance Highlights CMP. `495 Target Price - 4QFY2017 Result Update Pharmaceutical.

ACC NEUTRAL. Performance Highlights. CMP `1,261 Target Price - 4QCY2012 Result Update Cement. Quarterly results (Standalone) Investment Period -

Avenue Supermarts Limited

Maruti Suzuki ACCUMULATE. Performance Highlights. CMP `7,622 Target Price `8,501. 1QFY2018 Result Update Automobile

Ambuja Cements NEUTRAL. Performance Highlights CMP. `184 Target Price - 2QCY2012 Result Update Cement. Quarterly results (Standalone)

ICICI Bank BUY. Performance Highlights. CMP Target Price `307 `411. 1QFY2019 Result Update Banking. 3-year price chart. Key financials (Standalone)

Maruti Suzuki ACCUMULATE. Performance Highlights. CMP `5,715 Target Price `6,006. 2QFY2017 Result Update Automobile. 3-year price chart

Aster DM Healthcare Ltd

Dr. Reddy s Laboratories

Voltas BUY. Performance Highlights CMP. `327 Target Price `407. 4QFY2016 Result Update Construction & Eng. Quarterly highlights - Consolidated

Navkar Corporation BUY. Performance Update. CMP Target Price `175 `265. 2QFY2017 Result Update Logistics. Historical share price chart.

Bharat Dynamics Ltd SUBSCRIBE. Issue Open: Mar 13, 2018 Issue Close: Mar 15, IPO Note Defence. Key Financials

Wipro ACCUMULATE. Performance Highlights CMP. `539 Target Price `582. 1QFY2017 Result Update IT. Investment Period 12 Months

Tech Mahindra ACCUMLATE. Performance Highlights `495 `526. CMP Target Price. 2QFY2018 Result Update IT

Cadila Healthcare NEUTRAL. Performance Highlights CMP. `440 Target Price. 3QFY2017 Result Update Pharmaceutical. Investment Period -

Sandhar Technologies Limited

Dewan Housing Finance

Ambuja Cements NEUTRAL. Performance Highlights CMP. `155 Target Price - 1QCY2011 Result Update Cement. Investment Period - Key financials (Standalone)

Alembic BUY. Performance Highlights. Target Price. 1QFY2011 Result Update Pharmaceutical. Investment Period 12 months

Quick take. Aditya Birla Nuvo BUY. Deep Value. Valuation Methodology. Exhibit 1: ABNL s Business Structure

Cairn India ACCUMULATE. Performance Highlights. CMP Target Price `338 `382. 2QFY2013 Result Update Oil & Gas. Quarterly highlights (Consolidated)

Navkar Corporation BUY. Performance Update. CMP Target Price `200 `265. 4QFY2016 Result Update Logistics. Historical share price chart

Lupin BUY. Performance Highlights. CMP `1,493 Target Price `1,809. 2QFY2017 Result Update Pharmaceutical. 3-year price chart

Safari Industries BUY. On a fast paced Safari. Initiating Coverage Luggage February 21, CMP Target Price `532 ` year daily price chart

Transcription:

3QFY2019 Result Update Consumer Durable February 16, 2019 Amber Enterprises India Ltd Performance Update (` cr) 3QFY19 3QFY18 % yoy 2QFY19 % qoq Revenue 388.8 338.4 14.9 226.3 71.8 EBITDA 22.1 24.1 (8.2) 8.9 148.9 OPM (%) 5.7% 7.1% 3.9% Reported PAT 3.9 0.1 3123-1.8 (320.0) For 3QFY2019, Amber Enterprises Ltd (Amber) posted a decent set of numbers given muted demand environment and significant cost pressures. Revenue grew by 14.9% yoy to `338.8cr. On the bottom-line front, Amber reported PAT of `3.9cr against `0.1cr despite cost pressures. Growth led by AC Components Division: The company s top-line grew by 14.9% yoy to `338.8cr on the back of strong volume growth. Growth was led by strong performance of the AC Components division which accounted for 8.8% of revenues in Q4FY19 as compared to 5.9% of revenues in Q3FY18. Growth in the air conditioner segment was sluggish due to weakness in overall demand and therefore its contribution dropped to 78.4% of revenues from 80.9%. Non AC components contributed to 12.8% of revenues as compared to 13.2% of revenues in Q3FY18. Margins Impacted Due to Cost Pressures: On the operating front, the company s gross margins declined by 160bps to 14.1% due to cost pressures. EBITDA margins also declined by 130bps yoy to 5.7%. However lower interest outgo an stable tax rates led to increase in PAT from Rs. 0.1cr to Rs. 3.9cr. Outlook and Valuation: We expect Amber Ltd. to report net profit (reported) CAGR of ~35.5% to ~`114.4cr over FY2018-20E on the back of topline growth of 19.4% in the same period. Post the 3QFY19 numbers, we maintain BUY on the stock with a revised target Price of `910 (25xFY20E). Key Financials Y/E March (` cr) FY2017 FY2018 FY2019E FY2020E Net sales 1,651.9 2,128.1 2,500.5 3,034.7 % chg 51.7 28.8 17.5 21.4 Adj. Net profit 25.2 62.3 89.1 114.4 % chg 4.5 147.4 43.1 28.4 EBITDA margin (%) 7.9 8.6 7.5 7.5 EPS (`) 8.0 19.8 28.3 36.4 P/E (x) 79.5 32.1 22.5 17.5 P/BV (x) 6.0 2.2 2.1 1.9 RoE (%) 7.5 7.0 9.2 10.8 RoCE (%) 13.3 13.5 12.8 14.9 EV/Sales (x) 1.4 0.9 0.7 0.6 EV/EBITDA (x) 17.5 10.4 9.6 7.8 Note BUY CMP `637 Target Price `910 Investment Period 12 months Stock Info Sector Consumer Durable Market Cap (` cr) 2,002 Net Debt (` cr) -62.0 Beta 0.9 52 Week High / Low 1200/630 Avg. Daily Volume 12,500 Face Value (`) 2 BSE Sensex 35,809 Nifty 10,724 Reuters Code AMBER.BO Bloomberg Code AMBER.IN Shareholding Pattern (%) Promoters 44 MF / Banks / Indian 33 FII / NRIs / OCBs 11 Indian Public/Others 12 Abs.(%) 3m 1yr 3yr Sensex 1.6 4.4 52.0 Amber (25.9) (44.6) - Historical share price chart 1,400 1,200 1,000 800 600 400 200 0 Jan-18 Feb-18 Mar-18 Apr-18 May-18 Jun-18 Jul-18 Aug-18 Sep-18 Oct-18 Nov-18 Dec-18 Jan-19 Amarjeet S Maurya 022-40003600 Ext: 6831 amarjeet.maurya@angelbroking.com Please refer to important disclosures at the end of this report 1

Exhibit 1: 3QFY2019 Performance Y/E March (` cr) 3QFY19 3QFY18 % chg. (yoy) 2QFY19 % chg. (qoq) 9MFY19 9MFY18 % chg Net Sales 389 338 15 226 71.8 1,217 1,231 (1.1) Net raw material 334.0 285.3 17.1 186.1 79.5 1022 1034 (1.2) (% of Sales) 85.9 84.3 161 82.2 368 84.0 84.0 Employee Cost 10 9 5.4 10 1.2 29 28 6.0 (% of Sales) 2.5 2.8 (23) 4.3 (176) 2.4 2.2 Other Expenses 23 20 15.9 22 5.7 80 67 19.6 (% of Sales) 5.9 5.8 5 9.6 (368) 6.5 5.4 Total Expenditure 367 314 16.7 217 68.7 1,131 1,129 0.2 Operating Profit 22 24 (8.2) 9 148.8 86 102 (16.1) OPM (%) 5.7 7.1 (143) 3.9 176 7.1 8.3 (126) Interest 3 17 (79.2) 3 5.5 9.6 39.4 (75.6) Depreciation 12 11 11.3 12 (0.8) 36.5 31.9 14.6 Other Income 0 4 (93.0) 3 (89.9) 4.1 7.8 (47.3) PBT before exceptional 7 0 1,352.2 (4) (269.1) 44 39 12.5 (% of Sales) 1.7 0.1 (1.7) 3.6 3.2 Exceptional Items - PBT 7 0 1,352.2 (4) (269.1) 44 39 12.5 Tax 3 0 708.6 (2) (228.6) 12.9 10.8 19.2 (% of PBT) 42.4 76.1 55.7 29.4 27.8 Reported PAT 4 0 3,400.0 (2) (320.0) 31 28 10.0 PATM 1.0 0.0 (0.8) 2.5 2.3 Extra-ordinary Items Adj PAT 3.85 0.11 3,400.0 (1.75) (320.0) 31 28 10.0 February 16, 2019 2

Profit & Loss Statement Y/E March (` cr) FY2016 FY2017 FY2018 FY2019E FY2020E Total operating income 1,089.0 1,651.9 2,128.1 2,500.5 3,034.7 % chg -11.5 51.7 28.8 17.5 21.4 Total Expenditure 975.3 1,521.3 1,944.5 2,313.0 2,807.1 Raw Material 858.5 1,371.2 1,768.8 2,125.4 2,579.5 Personnel 36.5 43.7 49.8 50.0 60.7 Others Expenses 80.3 106.5 125.9 137.5 166.9 EBITDA 113.7 130.5 183.5 187.5 227.6 % chg 10.9 14.8 40.6 2.2 21.4 (% of Net Sales) 10.4 7.9 8.6 7.5 7.5 Depreciation& Amortisation 30.9 40.1 49.0 51.2 54.3 EBIT 82.9 90.4 134.5 136.3 173.3 % chg 7.6 9.1 48.8 1.3 27.2 (% of Net Sales) 7.6 5.5 6.3 5.5 5.7 Interest & other Charges 53.2 63.5 53.8 18.8 21.7 Other Income 3.1 8.8 8.7 10.5 12.6 (% of Sales) 0.3 0.5 0.4 0.4 0.4 Extraordinary Items - - - - - Share in profit of Associates - - - - - Recurring PBT 32.7 35.7 89.4 127.9 164.2 % chg -19.0 9.2 150.4 43.1 28.4 Tax 8.6 10.5 27.1 38.8 49.8 PAT (reported) 24.1 25.2 62.3 89.1 114.4 % chg -13.5 4.5 147.4 43.1 28.4 (% of Net Sales) 2.2 1.5 2.9 3.6 3.8 Basic & Fully Diluted EPS (Rs) 7.7 8.0 19.8 28.3 36.4 % chg -13.5 4.5 147.4 43.1 28.4 February 16, 2019 3

Balance Sheet Y/E March (` cr) FY2016 FY2017 FY2018 FY2019E FY2020E SOURCES OF FUNDS Equity Share Capital 21.7 23.8 31.4 31.4 31.4 Reserves& Surplus 240.9 311.1 861.3 936.5 1,033.0 Shareholders Funds 262.6 334.9 892.8 968.0 1,064.5 Minority Interest - - - - - Total Loans 326.6 344.9 105.5 100.0 100.0 Other Liab & Prov 80.8 46.8 64.4 75.7 91.9 Total Liabilities 670.0 726.6 1,062.7 1,143.7 1,256.4 APPLICATION OF FUNDS Net Block 536.1 577.5 739.8 789.8 839.8 Capital Work-in-Progress 2.0 3.0 4.0 5.0 6.0 Investments - - 5.7 55.7 105.7 Current Assets 533.6 650.4 964.0 1,081.6 1,259.7 Inventories 225.8 267.7 395.6 411.0 498.9 Sundry Debtors 247.9 310.4 378.6 411.0 498.9 Cash 18.4 34.7 133.8 176.3 161.5 Loans & Advances 40.6 37.1 28.3 50.0 60.7 Other Assets 1.0 0.5 27.6 33.1 39.8 Current liabilities 445.0 560.0 665.8 782.3 949.5 Net Current Assets 88.6 90.4 298.2 299.2 310.2 Other Non Current Asset 45.3 58.6 19.1 19.1 20.8 Total Assets 670.0 726.6 1,062.7 1,143.7 1,256.4 February 16, 2019 4

Cashflow Statement Y/E March (`cr) FY2016 FY2017 FY2018 FY2019E FY2020E Profit before tax 32.7 38.4 89.4 127.9 164.2 Depreciation 30.9 39.7 49.0 51.2 54.3 Change in Working Capital 42.9 (23.3) (67.7) (13.7) (84.8) Interest / Dividend (Net) - - - - - Direct taxes paid (10.5) (9.0) (27.1) (38.8) (49.8) Others (56.2) (52.7) (38.8) (5.4) 9.1 Cash Flow from Operations 152.2 98.5 82.4 132.1 74.8 (Inc.)/ Dec. in Fixed Assets (101.2) (82.0) (162.2) (50.0) (50.0) (Inc.)/ Dec. in Investments 1.4 0.8 - - - Cash Flow from Investing (83.9) (89.7) (162.2) (50.0) (50.0) Issue of Equity - 50.0 505.3 - - Inc./(Dec.) in loans 150.6 46.4 (239.4) (5.5) - Others 218.5 97.6 63.6 32.8 39.6 Cash Flow from Financing (67.9) (1.2) 202.3 (38.3) (39.6) Inc./(Dec.) in Cash 0.4 7.6 122.5 43.8 (14.8) Opening Cash balances 2.0 2.4 10.0 132.5 176.3 Closing Cash balances 2.4 10.0 132.5 176.3 161.5 February 16, 2019 5

Key Ratio Y/E March FY16 FY17 FY18E FY19E FY20E Valuation Ratio (x) P/E (on FDEPS) 83.1 79.5 32.1 22.5 17.5 P/CEPS 18.8 16.8 8.2 6.0 4.8 P/BV 7.6 6.0 2.2 2.1 1.9 Dividend yield (%) - - - - EV/Sales 2.1 1.4 0.9 0.7 0.6 EV/EBITDA 20.0 17.5 10.4 9.6 7.8 EV / Total Assets 3.4 3.1 1.8 1.6 1.4 Per Share Data (`) EPS (Basic) 7.7 8.0 19.8 28.3 36.4 EPS (fully diluted) 7.7 8.0 19.8 28.3 36.4 Cash EPS 33.9 37.9 77.9 105.4 131.7 Book Value 83.5 106.5 283.9 307.8 338.5 Returns (%) ROCE 14.1 13.3 13.5 12.8 14.9 Angel ROIC (Pre-tax) 13.7 13.9 15.9 16.3 19.0 ROE 9.2 7.5 7.0 9.2 10.8 Turnover ratios (x) Asset Turnover (Gross Block) 2.3 2.9 3.8 4.1 4.6 Inventory / Sales (days) 76 59 68 60 60 Receivables (days) 83 69 65 60 60 Payables (days) 95 99 98 98 98 Working capital cycle (ex-cash) (days) 64 29 35 22 22 February 16, 2019 6

Research Team Tel: 022-39357800 E-mail: research@angelbroking.com Website: www.angelbroking.com DISCLAIMER Angel Broking Limited (hereinafter referred to as Angel ) is a registered Member of National Stock Exchange of India Limited, Bombay Stock Exchange Limited and Metropolitan Stock Exchange Limited. It is also registered as a Depository Participant with CDSL and Portfolio Manager and Investment Adviser with SEBI. It also has registration with AMFI as a Mutual Fund Distributor. Angel Broking Limited is a registered entity with SEBI for Research Analyst in terms of SEBI (Research Analyst) Regulations, 2014 vide registration number INH000000164. Angel or its associates has not been debarred/ suspended by SEBI or any other regulatory authority for accessing /dealing in securities Market. Angel or its associates/analyst has not received any compensation / managed or co-managed public offering of securities of the company covered by Analyst during the past twelve months. This document is solely for the personal information of the recipient, and must not be singularly used as the basis of any investment decision. Nothing in this document should be construed as investment or financial advice. Each recipient of this document should make such investigations as they deem necessary to arrive at an independent evaluation of an investment in the securities of the companies referred to in this document (including the merits and risks involved), and should consult their own advisors to determine the merits and risks of such an investment. Reports based on technical and derivative analysis center on studying charts of a stock's price movement, outstanding positions and trading volume, as opposed to focusing on a company's fundamentals and, as such, may not match with a report on a company's fundamentals. Investors are advised to refer the Fundamental and Technical Research Reports available on our website to evaluate the contrary view, if any The information in this document has been printed on the basis of publicly available information, internal data and other reliable sources believed to be true, but we do not represent that it is accurate or complete and it should not be relied on as such, as this document is for general guidance only. Angel Broking Limited or any of its affiliates/ group companies shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. Angel Broking Limited has not independently verified all the information contained within this document. Accordingly, we cannot testify, nor make any representation or warranty, express or implied, to the accuracy, contents or data contained within this document. While Angel Broking Limited endeavors to update on a reasonable basis the information discussed in this material, there may be regulatory, compliance, or other reasons that prevent us from doing so. This document is being supplied to you solely for your information, and its contents, information or data may not be reproduced, redistributed or passed on, directly or indirectly. Neither Angel Broking Limited, nor its directors, employees or affiliates shall be liable for any loss or damage that may arise from or in connection with the use of this information. Disclosure of Interest Statement Amber Enterprises India 1. Financial interest of research analyst or Angel or his Associate or his relative No 2. Ownership of 1% or more of the stock by research analyst or Angel or associates or relatives No 3. Served as an officer, director or employee of the company covered under Research No 4. Broking relationship with company covered under Research No Ratings (Returns): Buy (> 15%) Accumulate (5% to 15%) Neutral (-5 to 5%) Reduce (-5% to -15%) Sell (< -15%) February 16, 2019 7